Take Action

News

News

Staying at the Forefront of Prescription Psychedelic Medicine

Track the latest federal regulatory milestones, clinical trial breakthroughs, and policy initiatives as we work to bring safe, FDA-approved therapies to patients in need.
The Data on Prescription Psychedelics is Clear
April 14, 2026

The Data on Prescription Psychedelics is Clear

Read more
Controlled Care: The Clinical Standard for FDA-Regulated Psychedelic Medicine
April 14, 2026

Controlled Care: The Clinical Standard for FDA-Regulated Psychedelic…

Read more
Medicine, Not a Movement: Why FDA Regulation is the Only Path Forward
April 14, 2026

Medicine, Not a Movement: Why FDA Regulation is…

Read more
The Human Stakes of Prescription Psychedelics
April 14, 2026

The Human Stakes of Prescription Psychedelics

Read more
Researchers Map the ‘Neural Fingerprint’ Shared by All Major Psychedelics
April 6, 2026

Researchers Map the ‘Neural Fingerprint’ Shared by All…

Read more
A Breakthrough Within Reach: Why Trump/Kennedy Should Lead on Psychedelic Medicine
April 1, 2026

A Breakthrough Within Reach: Why Trump/Kennedy Should Lead…

Read more
The Future of Biosynthesis: Engineering Tobacco for Multi-Compound Psychedelic Production
April 1, 2026

The Future of Biosynthesis: Engineering Tobacco for Multi-Compound…

Read more
Louisiana Senate Approves Opioid Settlement Funding for Psychedelic Clinical Trials
March 26, 2026

Louisiana Senate Approves Opioid Settlement Funding for Psychedelic…

Read more
Could psychedelics harness neuroplasticity to treat addiction and other mental illness?
January 13, 2026

Could psychedelics harness neuroplasticity to treat addiction and…

Read more